publication venue for
- 8. A Spherical Coordinate System for Tumor Identification in Positron Emission Tomography (PET) Imaging.. 3. 2000
- 8:45-9:00. Using PET 18F-FDG, 11CO, and 15O-water for Monitoring Prostate Cancer During a Phase II Anti-angiogenic Drug Trial with Thalidomide.. 3. 2000
- A Coordinate System for Tumor Identification in Positron Emission Tomography (PET) Imaging.. 3. 2000
- Quantitative Imaging of Yttrium-86 with PET. The Occurrence and Correction of Anomalous Apparent Activity in High Density Regions.. 3. 2000
- Whole-Body FDG-PET in Patients with Recurrent Colorectal Carcinoma. A Comparative Study with CT.. 3. 2000
- Tumor Burden Assessment with Positron Emission Tomography with. 3. 2000
- Defining the Role of FDG PET in Head and Neck Cancer.. 2. 1999
- Changes in FDG Tumor Uptake during and after Fractionated Radiation Therapy in a Rodent Tumor Xenograft.. 2. 1999
- FDG-PET in Esophageal Cancer. Incremental Value over Computed Tomography.. 2. 1999
- Differential Metabolism and Pharmacokinetics of L-[1-(11)C]-Methionine and 2-[(18)F] Fluoro-2-deoxy-D-glucose (FDG) in Androgen Independent Prostate Cancer.. 2. 1999
- Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.. 2. 1999
- PET Scanning with (18)F 2-Fluoro-2-Deoxy-D-Glucose (FDG) in Patients with Melanoma. Benefits and Limitations.. 2. 1999
- Radiation Dose Assessment for I-131 Therapy of Thyroid Cancer Using I-124 PET Imaging.. 2. 1999
- Accuracy of FDG-PET in Gastric Cancer. Preliminary Experience.. 1. 1998
- Quantitative Brain PET. Comparison of 2D and 3D Acquisitions on the GE Advance Scanner.. 1. 1998